Sicagen India Limited has submitted its quarterly compliance certificate to BSE Limited, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March, 2026.

Regulatory Compliance Filing

The company filed the certificate on April 16, 2026, in compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. The submission was made to BSE Limited's Department of Corporate Services, where Sicagen India Limited trades under scrip code 533014.

Registrar Confirmation

The certificate was issued by M/s. Cameo Corporate Services Limited, Chennai, which serves as the Registrar and Share Transfer Agent (RTA) for Sicagen India Limited. The RTA confirmed proper handling of dematerialization processes during the quarter under review.

Cameo Corporate Services Limited, through Manager (Shares) R. Vignesh Balaji, provided comprehensive confirmation regarding the company's compliance with depositories regulations. The certificate validates that all regulatory procedures were followed correctly during the quarter.

Compliance Confirmations

The certificate confirms several key compliance aspects for the quarter ended 31st March, 2026:

• Securities received from depository participants for dematerialization were properly confirmed to depositories
• All securities comprised in certificates have been listed on stock exchanges where earlier issued securities are listed
• Security certificates received for dematerialization were mutilated and cancelled after due verification
• Depository names were substituted in the register of members as registered owners within stipulated time limits

Documentation and Process

The filing includes the original certificate from the RTA dated April 3, 2026, along with the formal communication to BSE Limited. Company Secretary Ankita Jain digitally signed the submission, ensuring proper authorization and compliance with corporate governance requirements.

This quarterly filing demonstrates Sicagen India Limited's commitment to maintaining regulatory compliance and transparent reporting practices as required under SEBI regulations for listed companies.

Sicagen India Limited has announced a change in its senior management personnel, informing BSE Limited about the resignation of a key operations manager. The company made the disclosure under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Senior Management Personnel Change

Mr. V. Venkatesh, who served as Senior Manager-Operations in the Speciality Chemical Division, has submitted his resignation on March 25, 2026. The resignation was attributed to personal reasons, with the company confirming that there are no other material reasons for his departure.

Regulatory Compliance

The company has fulfilled its disclosure obligations by providing detailed information as required under SEBI regulations. The announcement includes all necessary documentation, including the formal resignation letter and annexures detailing the change in senior management personnel.

Sicagen India Limited confirmed that the resignation has been accepted by the company and Mr. Venkatesh will be relieved from his services on or before May 20, 2026. The disclosure was signed by Company Secretary Ankita Jain and made available on the company's website at www.sicagen.com .

Company Information

Sicagen India Limited operates as an ISO 9001:2015 certified company with its registered and corporate office located at 4th Floor, Spic House, 88, Mount Road, Guindy, Chennai. The company trades on BSE with scrip code 533014 and maintains its corporate identification number as L74900TN2004PLC053467.